MiRNA-based therapy for Stroke: MiRNA-375 inhibits cerebral ischemia induced injury via down regulation of its target gene, 28/January/2015, 08.24 am

Preserving the function of the guardian of the genome, p53: Rhamnetin, an O-methylated flavonol isolated from cloves, inhibits functional inactivation of p53 by somatic mutation and viral oncognes via up regulation of its target gene, 28/January/20145, 08.20 am
January 28, 2015
Molecular therapy for human cancers: WIF-1 increases the expression of tumor suppressor ARF, inhibits cancer stemness and induces senescence via up regulation of its target gene, 28/January/20145, 08.53 am
January 28, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, MiRNA-based therapy for Stroke: MiRNA-375 inhibits cerebral ischemia induced injury via down regulation of its target gene, 28/January/2015, 08.24 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests, for the first time, that MiRNA-375, by suppressing the expression of its target gene, it may inhibit cerebral ischemia induced injury.  Thus, pharmacological formulations encompassing “MiRNA-375 or its activators  may be used to inhibit cerebral ischemia induced injury.

Amount: $ 300

Undisclosed information: How MiRNA-375 inhibits cerebral ischemia induced injury

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.